W
Get Outlook for Android<https://aka.ms/ghei36>
________________________________
From: Parkinson's Information Exchange Network <[log in to unmask]> on behalf of Rayilyn Brown <[log in to unmask]>
Sent: Wednesday, January 29, 2020 11:49:05 PM
To: [log in to unmask] <[log in to unmask]>
Subject: Fwd: Google Alert - Parkinson's Disease vaccine
-------- Forwarded Message --------
Subject: Google Alert - Parkinson's Disease vaccine
Date: Wed, 29 Jan 2020 20:01:51 -0800
From: Google Alerts <[log in to unmask]>
To: [log in to unmask]
Google
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%3Fsource%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231410453&sdata=nEFWvPCP6l%2BTIZ1CRHdc7k%2BYfQaYs7hUpTJxy4%2FMwII%3D&reserved=0>
Parkinson's Disease vaccine
Daily update ⋅ January 30, 2020
NEWS
FDA Response Bolsters Affiris' Plans for Potential *Parkinson's Vaccine*
Affitope
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Furl%3Frct%3Dj%26sa%3Dt%26url%3Dhttps%3A%2F%2Fparkinsonsnewstoday.com%2F2020%2F01%2F29%2Ffda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope%2F%26ct%3Dga%26cd%3DCAEYACoTOTEzMjY2MDQ1MDIxODU0NzIzNTIaZDQ1NzQ0OTU2MTY4OTQ5MDpjb206ZW46VVM%26usg%3DAFQjCNGzyxpZrS304gRc-6nTbEPuMt3YZg&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231410453&sdata=aZxzhjQui1GuV3BAHUgv7ujDGcESTSw7gjf4WEYXSic%3D&reserved=0>
Parkinson's News Today
The U.S. Food *and* Drug Administration (FDA) has responded to Affiris'
pre-investigational new drug (IND) submission regarding a planned Phase
2 ...
Facebook
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%2Fshare%3Fhl%3Den%26gl%3DUS%26ru%3Dhttps%3A%2F%2Fparkinsonsnewstoday.com%2F2020%2F01%2F29%2Ffda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope%2F%26ss%3Dfb%26rt%3DFDA%2BResponse%2BBolsters%2BAffiris%2527%2BPlans%2Bfor%2BPotential%2BParkinson%2527s%2BVaccine%2BAffitope%26cd%3DKhM5MTMyNjYwNDUwMjE4NTQ3MjM1MhpkNDU3NDQ5NTYxNjg5NDkwOmNvbTplbjpVUw%26ssp%3DAMJHsmWGqzhRMojb11NN3_I7xS6zEtzVSw&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231410453&sdata=5vA7dRld4MLtIjrJ4E2JQTkpFr1vRCM927QqBUjVHyE%3D&reserved=0>
Twitter
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%2Fshare%3Fhl%3Den%26gl%3DUS%26ru%3Dhttps%3A%2F%2Fparkinsonsnewstoday.com%2F2020%2F01%2F29%2Ffda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope%2F%26ss%3Dtw%26rt%3DFDA%2BResponse%2BBolsters%2BAffiris%2527%2BPlans%2Bfor%2BPotential%2BParkinson%2527s%2BVaccine%2BAffitope%26cd%3DKhM5MTMyNjYwNDUwMjE4NTQ3MjM1MhpkNDU3NDQ5NTYxNjg5NDkwOmNvbTplbjpVUw%26ssp%3DAMJHsmWGqzhRMojb11NN3_I7xS6zEtzVSw&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=CJ3%2B1e0bAn65MR9moVxlWwhU6i6Lc3rYDVqgPvnfrD8%3D&reserved=0>
Flag as irrelevant
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%2Ffeedback%3Fffu%3Dhttps%3A%2F%2Fparkinsonsnewstoday.com%2F2020%2F01%2F29%2Ffda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope%2F%26source%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ%26s%3DAB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=phvF7LzfNQBzrd4CzW9GOQD5Nrkbz%2B%2BMrjFZTsAYYRE%3D&reserved=0>
See more results
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%3Fs%3DAB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw%26start%3D1579665849%26end%3D1580356911%26source%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ%23history&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=K6AVHxbRUgO8TEYms1Zu6xq%2FKsaL3Ajf1gHSTpHSskg%3D&reserved=0>
| Edit this alert
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%2Fedit%3Fsource%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ%26s%3DAB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw%26email%3Drayilynlee%2540cox.net&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=yZyWRr5sDduH5WEbLYcBnttk5aDiYY9rBQvDqXX4u7Q%3D&reserved=0>
You have received this email because you have subscribed to *Google
Alerts*.
Unsubscribe
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%2Fremove%3Fsource%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ%26s%3DAB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=aHOObQ5Lc5b7u3iTWSosoUgVhhfOeRsBnClCcI1Mvn0%3D&reserved=0>
| View all your alerts
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%3Fsource%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=sd%2BvdX1PSI2muKkm9Rtrf5817dhNirz5RvdAEZgaagE%3D&reserved=0>
RSS Receive this alert as RSS feed
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%2Ffeeds%2F04082120950631708698%2F17975067122935243170&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=DXsaflv2pOtd%2Fvf%2FRFzCNjP9fIm4RZ6Oyumf5ofc9Dg%3D&reserved=0>
Send Feedback
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%3Fsource%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ%26s%3DAB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw%26ffu&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=KKd3g3bDgj2yGsMPo7v0sRv85awAwjW9f7cWhJpusk4%3D&reserved=0=>
----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn
________________________________
From: Parkinson's Information Exchange Network <[log in to unmask]> on behalf of Rayilyn Brown <[log in to unmask]>
Sent: Wednesday, January 29, 2020 11:49:05 PM
To: [log in to unmask] <[log in to unmask]>
Subject: Fwd: Google Alert - Parkinson's Disease vaccine
-------- Forwarded Message --------
Subject: Google Alert - Parkinson's Disease vaccine
Date: Wed, 29 Jan 2020 20:01:51 -0800
From: Google Alerts <[log in to unmask]>
To: [log in to unmask]
Google
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%3Fsource%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231410453&sdata=nEFWvPCP6l%2BTIZ1CRHdc7k%2BYfQaYs7hUpTJxy4%2FMwII%3D&reserved=0>
Parkinson's Disease vaccine
Daily update ⋅ January 30, 2020
NEWS
FDA Response Bolsters Affiris' Plans for Potential *Parkinson's Vaccine*
Affitope
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Furl%3Frct%3Dj%26sa%3Dt%26url%3Dhttps%3A%2F%2Fparkinsonsnewstoday.com%2F2020%2F01%2F29%2Ffda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope%2F%26ct%3Dga%26cd%3DCAEYACoTOTEzMjY2MDQ1MDIxODU0NzIzNTIaZDQ1NzQ0OTU2MTY4OTQ5MDpjb206ZW46VVM%26usg%3DAFQjCNGzyxpZrS304gRc-6nTbEPuMt3YZg&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231410453&sdata=aZxzhjQui1GuV3BAHUgv7ujDGcESTSw7gjf4WEYXSic%3D&reserved=0>
Parkinson's News Today
The U.S. Food *and* Drug Administration (FDA) has responded to Affiris'
pre-investigational new drug (IND) submission regarding a planned Phase
2 ...
Facebook
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%2Fshare%3Fhl%3Den%26gl%3DUS%26ru%3Dhttps%3A%2F%2Fparkinsonsnewstoday.com%2F2020%2F01%2F29%2Ffda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope%2F%26ss%3Dfb%26rt%3DFDA%2BResponse%2BBolsters%2BAffiris%2527%2BPlans%2Bfor%2BPotential%2BParkinson%2527s%2BVaccine%2BAffitope%26cd%3DKhM5MTMyNjYwNDUwMjE4NTQ3MjM1MhpkNDU3NDQ5NTYxNjg5NDkwOmNvbTplbjpVUw%26ssp%3DAMJHsmWGqzhRMojb11NN3_I7xS6zEtzVSw&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231410453&sdata=5vA7dRld4MLtIjrJ4E2JQTkpFr1vRCM927QqBUjVHyE%3D&reserved=0>
Twitter
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%2Fshare%3Fhl%3Den%26gl%3DUS%26ru%3Dhttps%3A%2F%2Fparkinsonsnewstoday.com%2F2020%2F01%2F29%2Ffda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope%2F%26ss%3Dtw%26rt%3DFDA%2BResponse%2BBolsters%2BAffiris%2527%2BPlans%2Bfor%2BPotential%2BParkinson%2527s%2BVaccine%2BAffitope%26cd%3DKhM5MTMyNjYwNDUwMjE4NTQ3MjM1MhpkNDU3NDQ5NTYxNjg5NDkwOmNvbTplbjpVUw%26ssp%3DAMJHsmWGqzhRMojb11NN3_I7xS6zEtzVSw&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=CJ3%2B1e0bAn65MR9moVxlWwhU6i6Lc3rYDVqgPvnfrD8%3D&reserved=0>
Flag as irrelevant
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%2Ffeedback%3Fffu%3Dhttps%3A%2F%2Fparkinsonsnewstoday.com%2F2020%2F01%2F29%2Ffda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope%2F%26source%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ%26s%3DAB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=phvF7LzfNQBzrd4CzW9GOQD5Nrkbz%2B%2BMrjFZTsAYYRE%3D&reserved=0>
See more results
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%3Fs%3DAB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw%26start%3D1579665849%26end%3D1580356911%26source%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ%23history&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=K6AVHxbRUgO8TEYms1Zu6xq%2FKsaL3Ajf1gHSTpHSskg%3D&reserved=0>
| Edit this alert
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%2Fedit%3Fsource%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ%26s%3DAB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw%26email%3Drayilynlee%2540cox.net&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=yZyWRr5sDduH5WEbLYcBnttk5aDiYY9rBQvDqXX4u7Q%3D&reserved=0>
You have received this email because you have subscribed to *Google
Alerts*.
Unsubscribe
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%2Fremove%3Fsource%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ%26s%3DAB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=aHOObQ5Lc5b7u3iTWSosoUgVhhfOeRsBnClCcI1Mvn0%3D&reserved=0>
| View all your alerts
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%3Fsource%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=sd%2BvdX1PSI2muKkm9Rtrf5817dhNirz5RvdAEZgaagE%3D&reserved=0>
RSS Receive this alert as RSS feed
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%2Ffeeds%2F04082120950631708698%2F17975067122935243170&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=DXsaflv2pOtd%2Fvf%2FRFzCNjP9fIm4RZ6Oyumf5ofc9Dg%3D&reserved=0>
Send Feedback
<https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.google.com%2Falerts%3Fsource%3Dalertsmail%26hl%3Den%26gl%3DUS%26msgid%3DOTEzMjY2MDQ1MDIxODU0NzIzNQ%26s%3DAB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw%26ffu&data=02%7C01%7C%7C99bc629989af4d8f340408d7a552129b%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637159644231420445&sdata=KKd3g3bDgj2yGsMPo7v0sRv85awAwjW9f7cWhJpusk4%3D&reserved=0=>
----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn
----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn
